Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

How chlamydia hijacks a cell and hides from the immune system

Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

Chlamydia alternates between two completely different physical forms, one built for travel and one built for multiplication. Nothing else that infects humans does quite this.

The switch between them, and what it does to the cell in between, is the whole mechanism of the infection.

Illustration of small round yellow bacteria spilling out of a torn pink epithelial cell onto surrounding tissue.
The end of the cycle. After about two days inside the cell, hundreds of new elementary bodies are released to infect neighbouring cells. Some inclusions rupture the cell like this; others push out a package and leave the cell alive, which is one reason the infection can continue for months without causing noticeable inflammation.

Related pages: Chlamydia

The bottom line

What we know
  • The infectious form, the elementary body, is tough, small and metabolically inactive.
  • Inside the cell it converts into the reticulate body, which is fragile and divides rapidly.
  • It lives in a membrane compartment called an inclusion and takes nutrients and energy from the host cell.
  • After roughly 48 to 72 hours, new elementary bodies are released to infect other cells.
What is still open
  • How the signal to switch between the two forms is controlled.
  • How much of the damage comes from the infection itself versus the immune response to it.

The story, step by step

  1. 1. The elementary body ()
  2. 2. The reticulate body ()
  3. 3. Energy piracy ()
  4. 4. Evading destruction ()
  5. 5. The exit ()
What the evidence labels mean
GuidelineAn official recommendation from an expert group after weighing all the evidence.
Review of many studiesCombines the results of many studies (a systematic review or meta-analysis).
Randomized trialPeople were randomly given a treatment or a comparison, the best way to test cause and effect.
Large observational studyFollows many people over time. Shows strong links, but not always cause and effect.
Small or early studyA small study, case series, or first results. Needs to be confirmed.
Lab or animal studyDone in cells or animals. May not apply to people.
Part 1 of 5

Armour for the journey

Lab or animal study

What happens

The form that travels between people and between cells is built like a seed.

What the research shows

  • It is small, dense and metabolically dormant, doing essentially nothing while outside a cell.
  • Its outer membrane proteins are cross-linked by disulfide bonds, making a rigid shell that tolerates the hostile conditions of mucosal surfaces.
  • It cannot divide and cannot grow. Its only job is to reach a new cell and get inside.
  • Once attached, it triggers the cell to engulf it, so the cell does much of the work of its own infection.

Why it matters

A form that does nothing metabolically is also a form with very little for the immune system to notice.

What's still uncertain

  • Exactly which surface proteins drive attachment to host cells is still being worked out.

Read more

Next: The reticulate body

Part 2 of 5

Armour off, multiplication on

Lab or animal study

What happens

Once inside, the organism changes completely.

What the research shows

  • The disulfide cross-links are reduced, the shell loosens, and the particle expands into a larger, fragile form.
  • This reticulate body is metabolically active and divides by binary fission like an ordinary bacterium.
  • It stays within a membrane-bound compartment called an inclusion, which it modifies into a protected niche.
  • Hundreds of bacteria can accumulate inside a single inclusion in one cell.

Why it matters

The replicating form is defenceless outside a cell and the travelling form cannot replicate. Neither works alone, which is why the cycle exists.

What's still uncertain

  • What triggers conversion in either direction is not fully understood.

Read more

Next: Energy piracy

Part 3 of 5

Taking what it cannot make

Lab or animal study

What happens

Chlamydia has a drastically reduced genome and has lost the ability to make much of what it needs.

What the research shows

  • It carries nucleotide transport proteins that import ATP, the cell's energy currency, directly from the host.
  • Researchers have called it an energy parasite for this reason, and the term is literal rather than figurative.
  • The inclusion also intercepts vesicles from the host's Golgi apparatus, taking lipids, cholesterol and amino acids.
  • The bacterium is effectively plumbed into the cell's supply lines, which is why it needs a living cell rather than a dead one.

Why it matters

The dependence is total. This is why chlamydia cannot be cultured on an ordinary plate and why it was so hard to study.

What's still uncertain

  • How much of the infected cell's energy budget is diverted has been measured in culture rather than in people.

Read more

Next: Evading destruction

Part 4 of 5

Two switches, both turned off

Review of many studies

What happens

A cell that swallows a bacterium normally destroys it. Chlamydia prevents both of the cell's responses.

What the research shows

  • Normally the compartment holding a swallowed bacterium fuses with lysosomes, which digest the contents with acid and enzymes.
  • Chlamydia uses a type III secretion system, a needle-like apparatus that injects proteins into the host cell, to reroute the inclusion away from lysosomes.
  • It also blocks apoptosis, the cell's self-destruct program, which a cell would otherwise use to kill itself and the invader with it.
  • Because the bacterium sits inside a host cell and inside its own compartment, antibodies cannot reach it and most immune cells cannot either.

Why it matters

Hidden inside a cell is why antibiotics must be lipid-soluble enough to get in, and why penicillin-type drugs do not work.

What's still uncertain

  • The full set of injected effector proteins, and what each one does, is still being catalogued.

Read more

Next: The exit

Part 5 of 5

Burst, or slip out quietly

Lab or animal study

What happens

After roughly two to three days, the cycle completes.

What the research shows

  • Reticulate bodies condense back into elementary bodies, re-forming the rigid outer shell.
  • Some inclusions rupture the host cell, releasing everything at once.
  • Others extrude, pushing out a packaged portion while leaving the host cell alive.
  • Either way, hundreds to thousands of new infectious particles are released to infect neighbouring cells.
  • The cycle then repeats, and the infection spreads along the mucosal surface and sometimes upward into the uterus and fallopian tubes.

Why it matters

Extrusion without killing the cell is one reason infection can continue quietly for months with no inflammation anyone would notice.

What's still uncertain

  • Which exit route predominates in human infection, as opposed to cell culture, is not known.

Read more

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.